Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04724603 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phage Safety Retrospective Cohort Study

Study acronym: PHASACO-retro
StatusUnknown
PhaseNot specified
Started2021-02-01
View on ClinicalTrials.gov ↗

Amendment history

2026-09-06
Trial status changed: Recruiting → Unknown
2023-04-12
Study Status, Contacts/Locations v5
Study sitescontacts updated at 1 of 1 site
2022-09-26
Study Status, Study Design v4
Enrollment target14→25
2022-01-11
Study Status v3
Primary completion date2021-08-01→2022-08-01
Completion date2021-09-01→2026-09-01
2021-06-15
Study Status v2
Primary completion date2021-03-01→2021-08-01
Completion date2021-03-01→2021-09-01
2021-01-26
Study Identification, Study Status v1
Re-verified, no change to tracked fields
2021-01-22
Original filing
The aim of this study is to determine the imputability of adverse events in patients who have had phage therapy for the treatment of their bone or joint or implant infection, in order to find out whether these adverse effects are related to surgery, antibiotic treatment or bacteriophages.
Trial Details
NCT Number NCT04724603
Lead Sponsor Hospices Civils de Lyon
Conditions Bone and Joint Infection, Prosthetic Joint Infection
Enrollment 25 participants
Start Date 2021-02-01
Primary Completion 2022-08-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2023-04-13